We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+30.54%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$11.5B
AUM Growth
+$3.09B
(+37%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
12.85%
Top 10 Holdings %
Top 10 Hldgs %
9.43%
Holding
1,665
New
559
Increased
260
Reduced
246
Closed
589
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$91.6M |
| 2 |
Abbott
ABT
|
+$75M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$74.8M |
| 4 |
JPMorgan Chase
JPM
|
+$69.6M |
| 5 |
Alibaba
BABA
|
+$68.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$96.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$92.4M |
| 3 |
Johnson Controls International
JCI
|
+$76.9M |
| 4 |
Dollar General
DG
|
+$76.8M |
| 5 |
Boston Scientific
BSX
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.44% |
| 2 | Consumer Discretionary | 13.08% |
| 3 | Financials | 11.26% |
| 4 | Industrials | 10.99% |
| 5 | Healthcare | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Hope Bancorp
HOPE
$1.79B
| $415K | ﹤0.01% |
45,013
-71,711
| -61% | -$643K |
|
952
AXIS Capital
AXS
$7.43B
| $412K | ﹤0.01% |
+10,149
| New | +$391K |
|
953
CALL
Iovance Biotherapeutics
IOVA
$2.9B
| $412K | ﹤0.01% |
15,000
-190,200
| -93% | -$6.25M |
|
954
Federal Signal
FSS
$7.74B
| $403K | ﹤0.01% |
+13,540
| New | +$383K |
|
955
iShares China Large-Cap ETF
FXI
$4.35B
| $402K | ﹤0.01% |
+10,127
| New | +$395K |
|
956
American States Water
AWR
$3.43B
| $398K | ﹤0.01% |
+5,065
| New | +$404K |
|
957
CMS Energy
CMS
$21.7B
| $394K | ﹤0.01% |
+6,736
| New | +$390K |
|
958
Champion Homes
SKY
$5.05B
| $392K | ﹤0.01% |
+16,124
| New | +$336K |
|
|
CUK
959
DELISTED
Carnival PLC
CUK
| $390K | ﹤0.01% |
30,990
-18,875
| -38% | -$244K |
|
960
Trimble
TRMB
$13.6B
| $388K | ﹤0.01% |
+8,993
| New | +$337K |
|
961
Pathward Financial
CASH
$1.81B
| $387K | ﹤0.01% |
+21,308
| New | +$374K |
|
962
PTC Therapeutics
PTCT
$6.23B
| $386K | ﹤0.01% |
+7,598
| New | +$373K |
|
|
VBTX
963
DELISTED
Veritex Holdings
VBTX
| $385K | ﹤0.01% |
+21,764
| New | +$353K |
|
|
SP
964
DELISTED
SP Plus Corporation
SP
| $385K | ﹤0.01% |
+18,580
| New | +$383K |
|
965
Acadia Pharmaceuticals
ACAD
$5.06B
| $378K | ﹤0.01% |
+7,792
| New | +$374K |
|
966
ESCO Technologies
ESE
$7.79B
| $370K | ﹤0.01% |
4,379
-156
| -3% | -$12.3K |
|
967
CGI
GIB
$15.6B
| $365K | ﹤0.01% |
5,789
-16,829
| -74% | -$1.05M |
|
968
BOK Financial
BOKF
$8.7B
| $362K | ﹤0.01% |
+6,422
| New | +$329K |
|
969
Diodes
DIOD
$4.65B
| $362K | ﹤0.01% |
7,139
-19,510
| -73% | -$934K |
|
970
Neurocrine Biosciences
NBIX
$16.8B
| $348K | ﹤0.01% |
+2,856
| New | +$316K |
|
|
HOME
971
DELISTED
At Home Group Inc.
HOME
| $347K | ﹤0.01% |
+53,417
| New | +$219K |
|
|
TWNK
972
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $345K | ﹤0.01% |
28,247
-200,400
| -88% | -$2.37M |
|
973
WD-40
WDFC
$3.15B
| $344K | ﹤0.01% |
1,734
-3,089
| -64% | -$560K |
|
|
CUB
974
DELISTED
Cubic Corporation
CUB
| $343K | ﹤0.01% |
7,148
-9,626
| -57% | -$391K |
|
975
Tootsie Roll Industries
TR
$2.97B
| $342K | ﹤0.01% |
11,919
-336
| -3% | -$9.97K |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Balyasny Asset Management held 1,665 positions worth $11.5B, up 37% from $8.43B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Balyasny Asset Management deployed $1.48B of net new capital in Q2 2020, opening 559 new positions and adding to 260 existing holdings. Its largest new stake was Charles Schwab: 2,556,974 shares worth $86.3M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $96.4M trimmed.
- Balyasny Asset Management's largest Q2 2020 buy was Charles Schwab: 2,556,974 shares worth $86.3M.
- Balyasny Asset Management added most to Fiserv Inc in Q2 2020, an estimated $74.8M increase.
- Balyasny Asset Management's biggest Q2 2020 reduction was Lowe's Companies, cutting an estimated $96.4M.
- Balyasny Asset Management fully exited Allergan plc in Q2 2020, selling an estimated $92.4M.
- Balyasny Asset Management's ten largest holdings make up 9.4% of its $11.5B portfolio in Q2 2020.
- Balyasny Asset Management opened 559 new positions and closed 589 in Q2 2020.
- Balyasny Asset Management's portfolio value rose 37% quarter-over-quarter to $11.5B.
Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.